Beximco Pharmaceuticals receives DGDA approval to import Covid-19 vaccine from India

Date: January 5, 2021

Source: The Daily Star


Beximco Pharmaceuticals Ltd. has received approval from the Directorate General of Drug Administration (DGDA) to import the Oxford-AstraZeneca Covid-19 vaccine.

Ayub Hossain, spokesperson of DGDA, told The Daily Star that the drug regulatory authority has just given a no objection certificate (NOC) to Beximco Pharma to import the vaccine from Serum Institute of India.